Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Passage BIO, Inc. roe for the quarter ending 2026-06-30 was -810.41%, a change of -661.80% year-over-year.
Passage BIO, Inc. roe for the quarter ending 2026-03-31 was -320.59%, a change of -184.72% year-over-year.
Passage BIO, Inc. roe for the quarter ending 2025-12-31 was -242.72%, a change of -137.00% year-over-year.
Passage BIO, Inc. roe for the quarter ending 2025-09-30 was -145.45%, a change of -50.84% year-over-year.
Passage BIO, Inc. roe for fiscal 2025 was -242.72%, a change of -137.00% from fiscal 2024.
Passage BIO, Inc. roe for fiscal 2024 was -105.72%, a change of -14.01% from fiscal 2023.
Passage BIO, Inc. roe for fiscal 2023 was -91.71%, a change of -24.11% from fiscal 2022.
Passage BIO, Inc. roe for fiscal 2022 was -67.60%, a change of -9.42% from fiscal 2021.